Investor Update

Basel, 27 June 2019

Chugai Obtains Approval of FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic for Rozlytrek

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.